| 12391933 |
Targeted gene insertion for improved immune cells therapy |
Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton |
2025-08-19 |
|
| 12365733 |
Method for improving production of car T cells |
Alex BOYNE, Laurent POIROT, Alexandre Juillerat |
2025-07-22 |
|
| 12252699 |
Method for generating t-cells compatible for allogenic transplantation |
Laurent POIROT, David Sourdive, Jean-Pierre Cabaniols |
2025-03-18 |
|
| 12221478 |
Targeted gene integration of CRS inhibitor genes for improved immune cells therapy |
Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton, Mohit Sachdeva |
2025-02-11 |
|
| 12209125 |
Targeted gene integration of NK inhibitors genes for improved immune cells therapy |
Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton |
2025-01-28 |
|
| 12144825 |
Cellular immunotherapy for repetitive administration |
David Sourdive, Aymeric Duclert, Mathieu SIMON, Alan Marc WILLIAMS, Laurent POIROT |
2024-11-19 |
$565,000 |
| 11959091 |
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system |
Andre Choulika, Laurent POIROT |
2024-04-16 |
$2,536,000 |
| 11944643 |
Universal anti-CD22 chimeric antigen receptor engineered immune cells |
Julianne Smith, Murielle Derrien |
2024-04-02 |
$2,574,000 |
| 11912776 |
Chimeric antigen receptors targeting B-cell maturation antigen |
Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Roman Galetto, Alexandre Juillerat +6 more |
2024-02-27 |
$272,103,000 |
| 11903968 |
Engineered immune cells resistant to tumor microenvironment |
Anne-Sophie GAUTRON, Laurent POIROT, Julien Valton |
2024-02-20 |
$2,791,000 |
| 11873511 |
Targeted gene insertion for improved immune cells therapy |
Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton |
2024-01-16 |
$2,780,000 |
| 11820996 |
Method for generating T-cells compatible for allogenic transplantation |
Laurent POIROT, David Sourdive, Jean-Pierre Cabaniols |
2023-11-21 |
$3,180,000 |
| 11778993 |
Repeat variable diresidues for targeting nucleotides |
Alexandre Juillerat, Claudia Bertonati |
2023-10-10 |
$542,000 |
| 11767512 |
Sequence specific reagents targeting CCR5 in primary hematopoietic cells |
Toni CATHOMEN, Tatjana Cornu, Claudio MUSSOLINO, Marianna ROMITO, Agnes Gouble |
2023-09-26 |
$673,000 |
| 11692169 |
Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
Laurent POIROT |
2023-07-04 |
|
| 11690873 |
Universal chimeric antigen receptor T cells specific for CD22 |
Cécile SCHIFFER-MANNIOUI, Anne-Sophie GAUTRON |
2023-07-04 |
|
| 11685935 |
Compact scaffold of Cas9 in the type II CRISPR system |
Claudia Bertonati |
2023-06-27 |
$828,000 |
| 11674155 |
Sequential gene editing in primary immune cells |
Jean-Pierre Cabaniols, Jean-Charles Epinat |
2023-06-13 |
$937,000 |
| 11466291 |
Sequential gene editing in primary immune cells |
Jean-Pierre Cabaniols, Jean-Charles Epinat |
2022-10-11 |
|
| 11365430 |
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system |
Andre Choulika, Laurent POIROT |
2022-06-21 |
|
| 11312782 |
Chimeric antigen receptors targeting B-cell maturation antigen |
Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Roman Galetto, Alexandre Juillerat +6 more |
2022-04-26 |
$777,515,000 |
| 11220683 |
Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains |
Julien Valton |
2022-01-11 |
|
| 11198856 |
Method for the generation of compact tale-nucleases and uses thereof |
Julien Valton, Claudia Bertonati, Jean-Charles Epinat, George H. Silva, Alexandre Juillerat +1 more |
2021-12-14 |
|
| 11186824 |
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients |
Jean-Pierre Cabaniols, Julien Valton, Laurent POIROT |
2021-11-30 |
|
| 11136566 |
Tale-protein scaffolds and uses thereof |
Alexandre Juillerat, Julien Valton, Claudia Bertonati, Jean-Charles Epinat, George H. Silva |
2021-10-05 |
|
